AIM
TTPH

Alambic Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Alambic Investment Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,604
Closed -$43K – 420
2019
Q1 		$43K Sell
1,604
-4,140
-72% -$105K 0.02% 338
2018
Q4 		$130K Buy
5,744
+1,359
+31% +$53.1K 0.05% 268
2018
Q3 		$242K Buy
4,385
+3,495
+393% +$223K 0.19% 187
2018
Q2 		$64K Sell
890
-4,902
-85% -$346K 0.02% 340
2018
Q1 		$356K Buy
+5,792
New +$508K 0.05% 356

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Alambic Investment Management's TTPH Position: Q2 2019 in Review

Alambic Investment Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 1,604 shares — an estimated $43K sold.

Alambic Investment Management first reported a position in TTPH in Q1 2018 and held it in 5 quarters. The position peaked at $356K in Q1 2018. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • Alambic Investment Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Alambic Investment Management sold 1,604 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $43K.
  • Alambic Investment Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
  • Alambic Investment Management's Tetraphase Pharmaceuticals, Inc. position peaked at $356K in Q1 2018.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Alambic Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.